RE: RE: TRUST Upon FDA approval I had no action now as I had no EKG at the time of approval because they are not income. For cons, I follow MKI since their approval. I think they have a good product based on a system for selling recurring income regardless of economic cycles. I bought some shares in April and lately so I have not yet had the opportunity to sell. For what the title is $ 0.045, simply because the volume scan does not meet market expectations. As we have not heard from the company, it is difficult to know where we are going and the market does not like uncertainty. When will the new title will be up or down.